Bacterial Meningitis in Children: Causes, Symptoms & Treatment

Introduction

Bacterial meningitis represents a significant cause of morbidity and mortality in children worldwide. Meningitis is defined as inflammation of the protective membranes, known as meninges, that surround the brain and spinal cord (Chavez-Bueno & McCracken, 2005). The most common types of bacteria that cause bacterial meningitis in children aged 3 months and older are S. pneumoniae and N. meningitidis, which are responsible for 80% of cases in the United States (Brouwer et al., 2010). Symptoms of bacterial meningitis in children vary between infants and older children: infants typically present with fever, poor feeding, irritability, lethargy, and vomiting, while older children generally present with more clinically characteristic meningeal irritability, vomiting, photophobia, headache, and neck stiffness (Brouwer et al., 2010). Risk factors associated with bacterial meningitis in children include penetrating head injuries, neurosurgical procedures, and cerebrospinal fluid leaks (Chavez-Bueno & McCracken, 2005). Once the bacteria are present in the bloodstream, they penetrate the blood-brain barrier and enter the subarachnoid space, resulting in an intense inflammatory response.

Establishing a definitive diagnosis of bacterial meningitis requires a lumbar puncture and subsequent cerebrospinal fluid analysis (Chavez-Bueno & McCracken, 2005). Various antibiotic regimens are available for treatment, and recent studies have examined the use of corticosteroids in children to reduce hearing loss complications associated with bacterial meningitis (Mongelluzzo et al., 2008). Parents must be educated on the potential risk factors associated with meningitis, as well as potential outcomes such as hearing loss and learning disability. Lack of treatment and vaccination availability disproportionately affects disadvantaged children without access to necessary care; mortality levels are 5% in developed nations, while mortality in the developing world is approximately 30% (Best & Hughes, 2008). Bacterial meningitis poses a critical health threat to children, and it is imperative that parents recognize the symptoms of the infection and seek prompt treatment in order to increase a child's likelihood of survival.

This paper evaluates current literature to present a medical and educational overview of bacterial meningitis in the youth population. It discusses the global presence of bacterial meningitis, its symptoms, basic pathophysiology, diagnostic measures, treatment options, relevant patient and family education, underserved populations, and ethical implications.

Prevalence

Bacterial meningitis occurs when a bacterial pathogen infects the dural layers of the central nervous system and results in severe inflammation (Best & Hughes, 2008). Inflammation of the meninges is a serious condition that claims many lives and is responsible for a high incidence of disability with lasting effects on long-term health. The prevalence of bacterial meningitis is greatest in developing nations; every year, bacterial meningitis epidemics impact more than 400 million people in Africa alone (WHO, 2011). Over a 15-year period from 1996 to 2011, approximately 800,000 cases were reported in the "African meningitis belt," which extends from Senegal to Ethiopia.

In the United States, the prevalence of bacterial meningitis averages approximately 3 cases per 100,000 population, while incidence rates can average 101 cases per 100,000 in Niger (Brouwer et al., 2010). Studies from Brazil, Israel, Canada, and Northwest and Southern Europe show similar trends to those observed in the United States (Brouwer et al., 2010). Studies conducted by the Centers for Disease Control and Prevention indicate that males are more likely than females to contract bacterial meningitis — 3.3 versus 2.6 cases per 100,000 (Brouwer et al., 2010). The incidence disparity between developing and developed nations illustrates the effectiveness of conjugate vaccines and how their availability in developed nations has altered the epidemiology of bacterial meningitis.

Signs and Symptoms

Symptomatic manifestations of bacterial meningitis depend on the age of the child. Infants present with more nonspecific signs than older children, such as fever, vomiting, lethargy, irritability, and poor feeding (Brouwer et al., 2010). Older children have a greater probability of presenting with common signs of meningeal irritability, such as headache, photophobia, and neck stiffness (Brouwer et al., 2010); however, neck stiffness and altered mental status are less apparent in children than in adults (Chavez-Bueno & McCracken, 2005). Fever is one of the most common presenting symptoms in patients with bacterial meningitis, but is less frequent in infants aged 1–12 months (Best & Hughes, 2008). Although fever is a common complaint, it is not the defining symptom of bacterial meningitis. Seizure is a stronger indicator of bacterial meningitis in children outside the febrile convulsion age range of 6 months to 6 years (Best & Hughes, 2008).

Indicators of altered consciousness, ranging from confusion to coma, have also been studied as signs of bacterial meningitis in children. The degree of this symptom varies by age, as older children are more likely to present with coma than infants (Best & Hughes, 2008). Other manifestations are considered signs of bacterial meningitis only when evaluated in relation to other symptoms, including respiratory tract infections, headache, and gastrointestinal abnormalities (Best & Hughes, 2008). Some studies also identify rash as a sign in a limited number of childhood cases, while other studies report an absence of symptoms in certain patients, in which case lumbar puncture was the only means of diagnosis (Best & Hughes, 2008).

Conclusion

Bacterial meningitis is a significant cause of morbidity and mortality in children worldwide. Although mortality rates are greatest in developing nations, bacterial meningitis poses a critical health threat to the global youth population. Signs and symptoms depend on the age of the patient, with considerable variance between manifestations in infants and older children. Infants typically present with fever, poor feeding, irritability, lethargy, and vomiting, while older children may experience more common signs of meningeal irritability, neck stiffness, seizures, and varying degrees of altered consciousness. The two most common causative pathogens in children are S. pneumoniae and N. meningitidis; the incidence of Haemophilus influenzae type b (Hib) infection has largely decreased due to the availability of the Hib conjugate vaccine.

The basic pathophysiology of bacterial meningitis involves the bacterial pathogen crossing the blood-brain barrier and triggering an inflammatory response in the central nervous system, ultimately leading to cell death and loss of brain function. Lumbar puncture and cerebrospinal fluid analysis are required for a definitive diagnosis; developing sTREM-1 screening procedures, improved blood cultures, and refined skin biopsy techniques holds diagnostic potential for the future. Treatment involves various antibiotic regimens, with corticosteroid and anticonvulsant medications recommended to reduce adverse effects. The outcomes of bacterial meningitis in children vary by age and other factors; parents must be educated about risk factors and potential outcomes such as hearing loss and learning disability. Patients experiencing these outcomes may be referred to speech therapists and may require learning assistance to address the lasting effects of meningitis.

The lack of vaccine availability in developing nations isolates underserved populations and carries significant ethical implications. Prompt, accurate diagnosis of meningitis and the timely administration of the appropriate antibiotic are critical for a child's survival. Addressing the global inequity in vaccine access remains one of the most important challenges in reducing the worldwide burden of childhood bacterial meningitis.

References

Best, J., & Hughes, S. (2008). Evidence behind the WHO guidelines: hospital care for children — what are the useful clinical features of bacterial meningitis found in infants and children? Journal of Tropical Pediatrics, 54(2), 83–86.

Biernath, K., Reefhuis, J., Whitney, C., Mann, E., Costa, P., Eichwalk, J., & Boyle, C. (2006). Bacterial meningitis among children with cochlear implants beyond 24 months after implantation. Pediatrics, 117(2), 284–289.

Bingen, E., Levy, C., Rocque, F., Boucherat, M., Varon, E., & Alonso, J. (2005). Bacterial meningitis in children: a French prospective study. Clinical Infectious Diseases, 41, 1059–1063.

Brouwer, M., Tunkel, A., & Beek, D. (2010). Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis. Clinical Microbiology Reviews, 23(3), 467–492.

Ceyhan, M., Yildrim, I., Balmer, P., Borrow, R., & Dikici, B. (2008). A prospective study of etiology of childhood acute bacterial meningitis, Turkey. Emerging Infectious Diseases, 14(7), 1089–1096.

Chavez-Bueno, S., & McCracken, G. (2005). Bacterial meningitis in children. Pediatric Clinics of North America, 52, 985–1010.

Mongelluzzo, J., Mohamad, Z., Have, T., & Shah, S. (2008). Corticosteroids and mortality in children with bacterial meningitis. Journal of the American Medical Association, 299(17), 2048–2055.

Nigrovic, L., Malley, R., Macias, C., Kanegaye, J., & Moro-Sutherland, D. (2008). Effect of antibiotic pretreatment on cerebrospinal fluid profiles of children with bacterial meningitis. Pediatrics, 122(4), 726–730.

Roca, A., Bassat, Q., Morais, L., Machevo, S., Siguauque, B., Callaghan, C., & Nhamposa, T. (2009). Surveillance of acute bacterial meningitis among children admitted to a district hospital in rural Mozambique. Clinical Infectious Diseases, 48, 172–180.

World Health Organization. (2011). Meningococcal meningitis. Retrieved from

Yogev, R., & Guzman-Cottrill, J. (2005). Bacterial meningitis in children. Drugs, 65(8), 1097–1112.